Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LY4065967 for Diabetic Peripheral Neuropathic Pain
NCT07285018Phase 2Recruiting
- Sponsor
- Eli Lilly and Company
- Start
- Feb 2026
- Primary completion
- Jul 2027
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of LY4065967 in diabetic polyneuropathy (DPN), sponsored by Eli Lilly and Company. Started Feb 2026; status: recruiting.
02
Drugs
LY4065967
03
Conditions
diabetic polyneuropathy (DPN)
Beyond the preview
Go deeper on NCT07285018.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07285018.